# The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas

> **NCT03563313** · NA · COMPLETED · sponsor: **University of Virginia** · enrollment: 168 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** t:slim X2 with Control-IQ Technology & Dexcom G6 CGM
- **DEVICE:** Sensor-augmented pump (SAP)

## Key facts

- **NCT ID:** NCT03563313
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2019-04-08
- **Final completion:** 2019-04-08
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2020-04-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563313, "The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03563313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*